831 studies found for:    Open Studies | "Acquired Immunodeficiency Syndrome"
Show Display Options
Rank Status Study
21 Recruiting Neural Correlates of Working Memory Training for HIV Patients
Condition: HIV Infection
Intervention: Device: CogMedTM Training
22 Recruiting Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological Suppression
Condition: HIV Infection
Intervention: Other: Dolutegravir in a dual therapy regimen
23 Recruiting Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects
Condition: HIV Infections
Interventions: Biological: HIVAX;   Biological: saline solution;   Biological: Saline solution
24 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
25 Recruiting Microbiota Restoration Therapy in HIV With Repeated Low-Dose Interventions
Condition: HIV Infection
Interventions: Biological: FMT;   Other: Placebo
26 Recruiting Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection
Conditions: HIV;   Pregnancy
Interventions: Drug: Raltegravir;   Drug: Lopinavir/Ritonavir
27 Recruiting Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed Children
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Intervention: Drug: E/C/F/TAF
28 Recruiting 3BNC117 and 10-1074 in HIV Uninfected Adults
Condition: Human Immunodeficiency Virus
Interventions: Drug: 3BNC117;   Drug: 10-1074;   Drug: Placebo
29 Recruiting Dipyridamole for Immune Activation in HIV
Condition: HIV Infection
Interventions: Drug: Dipyridamole;   Drug: Placebo, then Dipyridamole
30 Recruiting IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV Persistence
Condition: HIV Infection
Intervention:
31 Recruiting Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection
Condition: Human Immunodeficiency Virus
Interventions: Drug: TwHF;   Drug: placebo treatment
32 Not yet recruiting Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects
Condition: HIV Positive
Interventions: Drug: darunavir/cobicistat;   Drug: rilpivirine
33 Recruiting Safety and Efficacy of MK-1439A in Participants Infected With Treatment-Naïve Human Immunodeficiency Virus (HIV) -1 With Transmitted Resistance (MK-1439A-030)
Condition: HIV-1 Infection
Intervention: Drug: MK-1439A
34 Recruiting Cognitive-Based Compassion Training (CBCT) for People Living With HIV (PLHIV)
Condition: Human Immunodeficiency Virus
Interventions: Behavioral: Cognitive-Based Compassion Training (CBCT);   Behavioral: Health discussion
35 Recruiting HIV Non-Occupational Post-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus
Intervention: Drug: Coformulated Elivitegravir (150mg), Combicistat (150mg), Emtricitabine (200mg), Tenofovir DF (300mg)
36 Recruiting Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Antiretroviral Therapy (Experimental)
37 Recruiting RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients
Condition: Chronic Infection With HIV
Interventions: Drug: Ritonavir boosted Atazanavir;   Drug: Raltegravir;   Drug: TDF/FTC (or 3TC)
38 Recruiting Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Condition: HIV Infections
Intervention:
39 Recruiting Evaluation of an Integrated Economic Strengthening and HIV Prevention Program for Vulnerable Youth in South Africa
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Economic Strengthening (Impumelelo);   Behavioral: HIV Prevention Education (Vhutshilo 2.2)
40 Recruiting Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-term Observational Study
Condition: HIV Infections
Interventions: Drug: Dolutegravir;   Drug: Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamid Fumarate;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Rilpivirine;   Drug: Lamivudine;   Drug: tenofovir;   Drug: Emtricitabine;   Drug: Abacavir

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.